Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19.
Ananworanich, Jintanat; Mogg, Robin; Dunne, Michael W; Bassyouni, Mohamed; David, Consuela Vera; Gonzalez, Erika; Rogalski-Salter, Taryn; Shih, Heather; Silverman, Jared; Medema, Jeroen; Heaton, Penny
[Article] Clinical Infectious Diseases.

(Format: HTML, PDF)